Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a rare condition characterized by high blood pressure in the arteries of the lungs, which can lead to symptoms like shortness of breath, fatigue, and chest pain.
Pulmonary Arterial Hypertension: Sotatercept Study
We are evaluating the long-term safety of sotatercept for adults with pulmonary arterial hypertension already on treatment. This study will help us understand how well it works when added to existing therapies.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Did you participate in a previous sotatercept PAH clinical trial?
- Have you missed more than 4 doses of your medication since your last study?
- Are you currently pregnant or breastfeeding?
- Do you have any ongoing serious health issues related to your previous sotatercept study?
- Are you willing to use effective contraception if you are a female of childbearing potential?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Ordensklinikum Linz GmbH
Interne 2 - Kardiologie, Angiologie & Interne Intensivmedizin
Linz, Austria
Allgemeines Krankenhaus Der Stadt Wien Universitatskliniken
Universitätsklinik für Innere Medizin II - Kardiologie
Vienna, Austria
UZ Leuven
Department of Pneumology and Respiratory Oncology
Heverlee, Belgium
Sponsor: Acceleron Pharma Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.